Gastroesophageal reflux disease in chronic obstructive pulmonary disease and asthma: Results from the China Pulmonary Health study

BACKGROUND: Gastroesophageal reflux disease (GERD) is a common comorbidity of chronic obstructive pulmonary disease (COPD) and asthma. However, limited information is available on GERD among community-sourced patients with COPD and asthma in China. This study aimed to assess the prevalence of GERD and its association with respiratory symptoms and airway reversibility in these patients from the general population. METHODS: The China Pulmonary Health (CPH) study, a national cross-sectional survey, enrolled 57,779 adults aged ≥20 years from June 2012 to May 2015. Participants completed standard questionnaires and underwent pulmonary function tests. GERD was defined using the Gastroesophageal Reflux Disease Questionnaire (GerdQ). Airway reversibility was assessed via post-bronchodilator pulmonary function changes. Multivariate regressions examined the association of GERD with respiratory symptoms and airway reversibility. RESULTS: In total, 47,226 participants were included in the final analysis. The prevalence of GERD was 6.62% (95% confidence interval [CI]: 5.89-7.34%) in patients with COPD, and 13.73% (95% CI: 12.19-15.27%) and 12.38% (95% CI: 9.84-14.93%) in patients with asthma and asthma with airflow limitation, respectively. GERD was associated with nasal symptoms, cough, sputum, wheezing, and dyspnea in patients with COPD. GERD was also associated with nasal symptoms and dyspnea in patients with asthma. After adjusting for confounders, the asthma group with GERD had smaller postbronchodilator changes in forced expiratory volume in 1 s (FEV1) compared with those without GERD (B = -0.030, 95% CI: -0.055 to -0.005, P = 0.018), and the association remained after further adjusting for respiratory symptoms (B = -0.033, 95% CI: -0.058 to -0.008, P = 0.009). But postbronchodilator changes in FEV1 or forced vital capacity (FVC) did not differ between COPD patients with and without GERD. CONCLUSIONS: GERD is prevalent and significantly associated with respiratory symptoms in patients with COPD and asthma. In patients with asthma, those with GERD had worse airway reversibility.

Authors

Institutions

Publication Details

Journal
Chinese Medical Journal
Published
2026-11-16
DOI
https://doi.org/10.1097/cm9.0000000000004309
Primary Topic
Gastroesophageal reflux and treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Gastroesophageal reflux disease in chronic obstructive pulmonary disease and asthma: Results from the China Pulmonary Health study

Yaodie Peng, Baicun Li, Ke Huang, Chen Wang et al.
Chinese Medical Journal
Gastroesophageal reflux and treatments
article

Gastroesophageal reflux disease in chronic obstructive pulmonary disease and asthma: Results from the China Pulmonary Health study

Yaodie Peng, Baicun Li, Ke Huang, Chen Wang, Ting Yang, Xingyao Tang
article en

Abstract

BACKGROUND: Gastroesophageal reflux disease (GERD) is a common comorbidity of chronic obstructive pulmonary disease (COPD) and asthma. However, limited information is available on GERD among community-sourced patients with COPD and asthma in China. This study aimed to assess the prevalence of GERD and its association with respiratory symptoms and airway reversibility in these patients from the general population. METHODS: The China Pulmonary Health (CPH) study, a national cross-sectional survey, enrolled 57,779 adults aged ≥20 years from June 2012 to May 2015. Participants completed standard questionnaires and underwent pulmonary function tests. GERD was defined using the Gastroesophageal Reflux Disease Questionnaire (GerdQ). Airway reversibility was assessed via post-bronchodilator pulmonary function changes. Multivariate regressions examined the association of GERD with respiratory symptoms and airway reversibility. RESULTS: In total, 47,226 participants were included in the final analysis. The prevalence of GERD was 6.62% (95% confidence interval [CI]: 5.89-7.34%) in patients with COPD, and 13.73% (95% CI: 12.19-15.27%) and 12.38% (95% CI: 9.84-14.93%) in patients with asthma and asthma with airflow limitation, respectively. GERD was associated with nasal symptoms, cough, sputum, wheezing, and dyspnea in patients with COPD. GERD was also associated with nasal symptoms and dyspnea in patients with asthma. After adjusting for confounders, the asthma group with GERD had smaller postbronchodilator changes in forced expiratory volume in 1 s (FEV1) compared with those without GERD (B = -0.030, 95% CI: -0.055 to -0.005, P = 0.018), and the association remained after further adjusting for respiratory symptoms (B = -0.033, 95% CI: -0.058 to -0.008, P = 0.009). But postbronchodilator changes in FEV1 or forced vital capacity (FVC) did not differ between COPD patients with and without GERD. CONCLUSIONS: GERD is prevalent and significantly associated with respiratory symptoms in patients with COPD and asthma. In patients with asthma, those with GERD had worse airway reversibility.

Chinese Medical Journal
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), China-Japan Friendship Hospital (CN)
National Science and Technology Major Project, China-Japan Friendship Hospital
Good health and well-being
Gastroesophageal reflux and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon